Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Faberlic is a private Russian direct-selling consumer products company best known for cosmetics, skincare, personal care, fragrances, household products, apparel, and selected wellness and dietary supplement offerings. The business was founded in 1997 as Russian Line and later rebranded to Faberlic, with brand positioning centered on oxygen-based cosmetics and broad mass-market beauty products. It operates commercially rather than as a drug development company and does not appear to run a biopharma pipeline, clinical-stage therapeutics portfolio, or healthcare R&D organization. For biotech and pharma diligence purposes, Faberlic is better classified as a beauty, personal care, and wellness products company than as a life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Faberlic.